Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Q2 2020 Earnings Conference Call - Final Transcript
Aug 10, 2020 • 04:30 pm ET
outstanding progress on our pipeline and our commercial build-out in anticipation of a potential approval and launch for ROLONTIS. I'd like to thank our entire team for their hard work and their dedication in these unprecedented times.
And with that, I'd like to open the lines for questions. Operator, If you could open up the lines for questions, I'd appreciate it.